90944-62-0

Basic information

• Product Name: 4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE
• Synonyms: N,N-DIETHYL 4-BROMOBENZENESULFONAMIDE;4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE;4-Bromo-N,N-diethylbenzenesulphonamide 97%;4-Bromo-N,N-diethylbenzenesulphonamide97%
• CAS NO: 90944-62-0
• Molecular Formula: C₁₀H₁₄BrNO₂S
• Molecular Weight: 292.19
• Product Categories: blocks;Bromides;Sulfonamides;alkyl bromide
• Mol File: 90944-62-0.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 356.4 °C at 760 mmHg
• Flash Point: 169.3 °C
• Appearance: /
• Density: 1.431g/cm³
• Vapor Pressure: 2.93E-05mmHg at 25°C
• Refractive Index: 1.556
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE(90944-62-0)
• EPA Substance Registry System: 4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE(90944-62-0)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 90944-62-0(Hazardous Substances Data)

Usage

General Description

4-Bromo-N,N-diethylbenzenesulfonamide is a chemical compound with the molecular formula C10H14BrNO2S. It is a white crystal powder that is commonly used as an intermediate in the synthesis of pharmaceuticals. 4-BROMO-N,N-DIETHYLBENZENESULPHONAMIDE can act as a bacteriostatic agent and is known for its antimicrobial properties. It is also used in the production of pesticides and other agrochemicals. Additionally, 4-Bromo-N,N-diethylbenzenesulfonamide is utilized as a precursor in the synthesis of dyes and other organic compounds. Its strong antibacterial and antifungal properties make it a valuable compound in various industries, particularly in the pharmaceutical and agricultural sectors.

InChI:InChI=1/C10H14BrNO2S/c1-3-12(4-2)15(13,14)10-7-5-9(11)6-8-10/h5-8H,3-4H2,1-2H3

Upstream product

• 109-89-7 diethylamine 
• 98-58-8 4-bromobenzenesulfonyl chloride 
• 150-77-6 N,N,N',N'-Tetraethylethylenediamine 
• 34176-08-4 sodium 4-bromobenzenesulfinate 
• 121-44-8 triethylamine 
• 2297-64-5 p-bromophenylsulfonyl hydrazide 
• 589-87-7 1,4-bromoiodobenzene 

Downstream Products

• 308110-14-7 N,N-diethyl-4-[hydroxy(phenyl)methyl]benzenesulfonylamide 

Relevant articles and documents

MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF ASSOCIATED DISEASES

Mitochondrial targeting compounds for the treatment of cancer and other disorders associated with mitochondrial function, including diabetes, autoimmune diseases, inflammatory diseases, cardiovascular diseases and neurodegenerative diseases and their preparation. The present invention is also directed to the pharmaceutical compositions and treatment methods, prodrugs based on those compounds and the use thereof.

NaI-Catalyzed Oxidative Amination of Aromatic Sodium Sulfinates: Synergetic Effect of Ethylene Dibromide and Air as Oxidants

A novel NaI-catalyzed oxidative amination of sodium sulfinates, employing both ethylene dibromide (EDB) and air as the oxidants, is described. EDB was first demonstrated to be a promising mild organic oxidant that in air, converted NaI into molecular iodine to promote the cross-coupling reactions of aromatic sodium sulfinates with amines to produce arylsulfonamides. Mechanistic studies indicated that a radical pathway might be involved in the reaction process.

NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT

The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, comprising same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.